Navigating the wait: study tests whether a guide can speed up breast cancer diagnosis

NCT ID NCT05181722

Completed Knowledge-focused Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study looks at whether having a patient navigator—a person who helps guide you through the healthcare system—can help women get timely follow-up care after an abnormal mammogram. The COVID-19 pandemic caused many delays in cancer diagnosis, especially for at-risk groups. Researchers at Johns Hopkins are tracking 196 women to see if navigation improves follow-up rates within 30 days and reduces anxiety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Patient navigator support
What this could lead to: If effective, patient navigation could become a standard tool to reduce delays in breast cancer diagnosis, especially for vulnerable populations.
What could go wrong: This is a small, single-site study with no control group, so results may not apply broadly. The intervention is supportive, not a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Johns Hopkins Breast Imaging clinics

Baltimore, Maryland, 21093, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.